Pharmasimple SA
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Pharmasimple SA - overview
Established
2010
Location
-, Brusells, Belgium
Primary Industry
Internet
About
Based in Houdeng-Goegnies, Belgium, and founded in 2010, Pharmasimple SA operates as an online marketing platform that offers various para-pharmaceutical products for beauty, slimming, hygiene, pets, and more. The company was Co-founded by its CEO Michael Willems and Annabelle Willems. In October 2016, Pharmasimple SA raised EUR 1 million in venture funding led by News Invest and Sopromec Participations. As of 2023, the company has an employee count of 75 employees.
The firm offers various products under the name Clinique, Horace, and See. It offers products for beauty, health, slimming, and sports, animals, hygiene and sexuality, etc. It offers products for acne, face accessories, make-up removal accessories, and products for hair, body, makeup, water, perfume, etc. It also offers diet and meal replacement supplements, along with alternate medicines.
Current Investors
Sopromec Participations, Atout Capital, News Invest
Primary Industry
Internet
Sub Industries
Accessories, Beauty & Hygiene, Health Foods & Nutritional Supplements, Drug Stores/Convenience Stores, Alternative Medicine
Website
www.pharmasimple.com
Verticals
E-commerce
Company Stage
Mature
Total Amount Raised
Subscriber access only
Pharmasimple SA - timeline of key events

Pharmasimple SA - financials
| Fiscal Year Ended | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | - | - | - | - | 19,067,063 | 16,166,190 | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - | (15.2%) | - | - | - |
| EBITDA (USD) | 70,249 | 213,984 | 148,214 | (474,547) | (981,261) | (1,622,039) | - | - | - |
| Operating Income (USD) | (1,185) | 113,165 | (46,740) | (740,997) | (1,293,287) | (2,136,959) | - | - | - |
| Operating Margin | - | - | - | - | (6.8%) | (13.2%) | - | - | - |
| % EBITDA Margin | - | - | - | - | (5.1%) | (10.0%) | - | - | - |
| NET Income (USD) | (86,329) | 46,354 | (421,282) | (941,372) | (1,370,373) | (2,238,452) | - | - | - |
| % Net Margin | - | - | - | - | (7.2%) | (13.8%) | - | - | - |
Pharmasimple SA - employee data


Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.